Inventor · disambiguated record
Carla Heise
Also filed as: HEISE CARLA · HEISE CARLA C
7 granted patents·14 pending applications·136 citations·filing 1999–2015
85Inventor score
Files withNOVARTIS VACCINES & DIAGNOSTIC5CHIRON CORP4NOVARTIS AG3HEISE CARLA2ABRAXIS BIOSCIENCE LLC1
Top patents by PatentIndex Score
21 records- 0189US8158360B2Effects of inhibitors of FGFR3 on gene transcriptionHEISE CARLA·Filed 2006·Granted Apr 17, 2012·67 cites·34 claims
- 0289US7470709B2Benzimidazole quinolinones and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Dec 30, 2008·36 cites·17 claims
- 0383US7825132B2Inhibition of FGFR3 and treatment of multiple myelomaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Nov 2, 2010·19 cites·9 claims
- 0482US7875624B2Modulating and measuring cellular adhesionNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Jan 25, 2011·7 cites·18 claims
- 0567US7838527B2Methods of treating cancer and related methodsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Nov 23, 2010·5 cites·47 claims
- 0665US8299081B2Methods for treating drug resistant cancerMICHELSON GLENN C·Filed 2006·Granted Oct 30, 2012·2 cites·20 claims
- 0759US2009281100A1Benzimidazole quinolinones and uses thereofBARSANTI PAUL A·Filed 2008·Application pending·0 cites
- 0856US2016008344A1Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictorCELGENE CORP·Filed 2015·Application pending·0 cites
- 0955US2011223157A1Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictorSCHAFER PETER H·Filed 2011·Application pending·0 cites
- 1054US2005203101A1Benzimidazole quinolinones and uses thereofCHIRON CORP·Filed 2004·Application pending·0 cites
- 1151US2010173873A1Treatment of metastasized tumorsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 1250US2006269515A1Interleukin-2 muteinsCHIRON CORP·Filed 2005·Application pending·0 cites
- 1348US2014199404A1Method for treating cancer based on level of a nucleoside transporterABRAXIS BIOSCIENCE LLC·Filed 2013·Application pending·0 cites
- 1448US2006251617A1Methods for treating lymphomasCHIRON CORP·Filed 2006·Application pending·0 cites
- 1546US2010004253A1Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitorsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1645US2006183750A1Treatment of metastasized tumorsCHIRON CORP·Filed 2006·Application pending·0 cites
- 1744US2010086518A1Treatment of melanomaNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1842US8288087B2Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanomaTAN NGUYEN·Filed 2007·Granted Oct 16, 2012·0 cites·14 claims
- 1940US2012149714A1Effects of Inhibitors of FGFR3 on Gene TranscriptionHEISE CARLA·Filed 2012·Application pending·0 cites
- 2039US2013237546A1Use of melanoma inhibitory activity (mia) protein as an early indicator for therapeutic response in melanomaNOVARTIS AG·Filed 2012·Application pending·0 cites
- 2123US2002037274A1Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutantsFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carla Heise files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →